Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,165 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03466619Recruiting
Penile implant surgery for erectile dysfunction when medicines fail
This trial looks at using a penile implant pump to help erections in people whose erectile dysfunction can’t be fixed with standard medicine or can’t safely take it. It may help if pills or other treatments have not worked for you, but it also requires the ability to use the device correctly and safely.
Cairo, ElgharbiaAges 18–80 - NCT03250091Recruiting
Stomach precancer check-up study after scope
This study follows people who have had an upper endoscopy (a camera test through the mouth to look at the stomach) to monitor precancerous stomach changes. It may help doctors learn the best way to watch these spots over time and catch problems early.
RigaAges 18 years+ - NCT02865330Recruiting
Registry study for men on active surveillance for low-risk prostate cancer
This is a registry study that follows men with low-risk prostate cancer who choose active surveillance instead of immediate treatment. It helps doctors understand how safe and effective active surveillance is, including confirming results with repeat biopsies.
ValenciaAges 18–80 - NCT03712774Recruiting
Study of how chemoradiation affects quality of life
This observational study follows people with esophageal cancer to see how their quality of life changes after chemoradiation. It does not change your treatment, but it may help doctors better understand what to expect during and after therapy.
Munich, BavariaAges 18 years+ - NCT03463564RecruitingPhase 4
Insulin pump versus insulin shots for type 1 diabetes control
This study compares an insulin pump to insulin shots to see which better improves blood sugar control and reduces swings in people with type 1 diabetes. You may be included if your diabetes is not well controlled despite education and you’ve had low blood sugar episodes.
NaplesAges 18–30 - NCT03731442RecruitingPhase 3
Radiation plus chemotherapy for esophageal cancer that came back
This Phase 3 trial studies giving combined chemotherapy and radiation to treat esophageal cancer that has returned after earlier surgery and/or prior treatments. It may help control the cancer in the area where it comes back, especially when the surgical margins were not fully clear or the cancer is outside the original radiation field.
Beijing, Beijing MunicipalityAges 16–70 - NCT03792854Recruiting
Quality-of-life study after standard treatment for anal cancer
This observational study follows people with anal cancer to understand how their quality of life changes after they receive standard chemoradiation therapy. It may help doctors better support patients with symptoms, recovery, and daily functioning over time.
Munich, BavariaAges 18 years+ - NCT03498326RecruitingPhase 2
Gemcitabine plus celecoxib after pancreatic surgery
This trial tests whether adding celecoxib to gemcitabine chemotherapy after complete (R0) pancreatic tumor removal can lower the chance the cancer comes back. It may help people who have had successful surgery but still need anti-cancer treatment.
Hangzhou, ZhejiangAges 18–90 - NCT03561740RecruitingPhase 3
Capecitabine plus usual treatment for high-risk HER2 breast cancer
This trial looks at whether adding a chemotherapy medicine called capecitabine (taken in smaller, regular doses) to the standard after-surgery (adjuvant) treatment can lower the chance of cancer coming back in people with early-stage, high-risk HER2-positive breast cancer. It targets patients who still had cancer left after earlier treatment or who had higher-risk tumor features.
Guangzhou, GuangdongAges 18–70 - NCT02901392Recruiting
Sling or artificial urinary sphincter after prostate cancer
This registry study follows men who have ongoing “stress” urine leakage after prostate cancer treatment and choose a sling or an artificial urinary sphincter. It aims to better understand outcomes and quality of life, and your care team uses check-in visits and questionnaires to track progress.
ValenciaAges 18 years+ - NCT03731130Recruiting
Study on quality of life after rectal cancer treatment and surgery
This observational study follows people with rectal cancer who get radiation (with or without chemotherapy) before surgery. It aims to understand how these treatments affect quality of life after surgery.
Munich, BavariaAges 18 years+ - NCT02967822Recruiting
Study of genes in MRKH syndrome and related families
This study looks at DNA (your genes) to better understand Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. It may help researchers learn more about the condition, and it can include both people with MRKH and healthy family relatives.
ParisAges Any age - NCT04025450RecruitingPhase 1/Phase 2
Tested stronger combo for high-risk myeloma patients
This early-phase study compares two drug combinations—chidamide plus VRD versus VRD alone—to see which works better for primary high-risk multiple myeloma. The goal is to improve response while closely monitoring side effects and heart/lung safety.
Suzhou, JiangsuAges 18–80 - NCT03781531Recruiting
Blood tests to find hidden cancer after a blood clot
This study looks for “biomarkers,” or blood signs, that may help detect hidden (occult) cancer in people who recently had a blood clot in the leg or a lung clot. It may help doctors catch cancer earlier by improving detection after venous thromboembolism.
StockholmAges 18 years+ - NCT03772275Recruiting
Tests new blood markers in chronic heart failure patients
This study looks at whether certain new blood tests (biomarkers) can help doctors learn more about chronic heart failure. You might be asked for blood samples and health information, and the results could improve how heart failure is understood in the future.
Tanta, ElgharbiaAges 18–75 - NCT02762162Recruiting
Registry of heart artery patients’ platelet test results
This registry collects information from people with coronary (heart) artery disease who already had platelet-related blood tests as part of usual care. The goal is to better understand how platelet responses relate to treatment and outcomes, which may help future care.
ParisAges 18 years+ - NCT03392337Recruiting
Narrowband UVB light therapy for moderate to severe plaque psoriasis
This study tests whether narrowband ultraviolet B (UVB) light given three times a week for 12 weeks improves moderate-to-severe plaque psoriasis. It is an “open-label” pilot, meaning everyone gets the UVB treatment and researchers track how your skin responds.
East Windsor, New JerseyAges 18 years+ - NCT03837574Recruiting
Registry for people with Tetralogy of Fallot and a defibrillator
This is a national registry that collects information about people with Tetralogy of Fallot who have an implantable defibrillator. It helps researchers better understand outcomes and care needs in this specific group.
ParisAges 18 years+ - NCT03883269RecruitingPhase 4
Tests topical antibiotics’ anti-inflammatory effect in acne
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
LeidenAges 18–45 - NCT03886662RecruitingPhase 1/Phase 2
LB-100 for low-risk MDS after prior treatment failure
This Phase 1/2 trial studies LB-100 in adults with low or intermediate-1 risk myelodysplastic syndromes (MDS). It may help by improving blood counts or disease control in people whose prior treatments have not worked or stopped working.
Tampa, FloridaAges 18 years+ - NCT03949400Recruiting
Exercise therapy and a soft knee brace for knee arthritis
This study tests whether an exercise program plus education, along with a soft brace, helps improve symptoms and function in adults with knee osteoarthritis. It may help people who have knee pain by combining movement training with daily support.
Aalborg, NothernAges 18 years+ - NCT03048266Recruiting
Testing genes and blood chemistry in MEN1 pancreatic tumors
This study looks at blood chemistry (metabolomics) and genetic information in people who have MEN1, especially if they are being evaluated for pancreatic neuroendocrine tumors. It may help doctors better diagnose these tumors by finding patterns in test results.
Houston, TexasAges Any age - NCT03966443Recruiting
Fluciclovine PET/CT scan for people with multiple myeloma
This trial studies how a special PET/CT scan (using fluciclovine) may help doctors evaluate multiple myeloma. You might be eligible if you’re a candidate for stem cell transplant (ASCT).
OsloAges 18 years+ - NCT03980002RecruitingPhase 2
New treatment for CLL using alternating two drug types
This trial studies an approach for people with newly diagnosed CLL/SLL (chronic lymphocytic leukemia or related disease) who need treatment. It tests whether alternating two types of chemotherapy with ibrutinib (a targeted pill) can control the disease better and safely.
Tianjin, Tianjin MunicipalityAges 18–75
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,165 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.